Observational studyPloS one2025

An anonymized, de-identified registry study protocol to determine the effectiveness and safety of weight loss with enavogliflozin in patients with type 2 diabetes mellitus.

Hyunji Sang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.